QJS: Interoperable Automated Glycemic Controller, Insulin Suspend: FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (2020 to 2020)
U.S. FDA CDRH three-letter product classification QJS in Clinical Chemistry reconciled across 2020 to 2020.
Review 1 FDA 510(k) clearances, 1 recalled K-numbers, and 0 cumulative 1976 to 2026 CDRH recall notices for QJS: Interoperable Automated Glycemic Controller, Insulin Suspend on Predicate Ledger.
| Regulatory Metric | Verified Value |
|---|---|
| Entity Classification | FDA 3-Letter Product Code (QJS) |
| Clinical Advisory Specialty | Clinical Chemistry (Panel CH) |
| Cleared FDA 510(k) Submissions (1976 to 2026) | 1 clearances (1 California, 100.0%) |
| Cleared 510(k)s Linked to a Recall Notice | 1 K-numbers |
| Cumulative Historical Recall Notices (1976 to 2026) | 0 notices (0 Class I, 0 Class II, 0 Class III) |
| Currently Open vs Historical Recall Status | Cumulative 1976 to 2026 FDA archive total; inspect individual event statuses in dossier or live FDA Enforcement Reports |
Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.